CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Health Research and Analysis - HRA has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 HEOR Solutions Companies - 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

Health Research and Analysis - HRA
Delivering Actionable Insights for Better Health

Health Research and Analysis - HRA

Samar DeBakey, MD, MPH, president., Health Research and Analysis - HRASamar DeBakey, MD, MPH, president.
Policymakers and healthcare systems rely on real-world evidence from health economics and outcomes research (HEOR) to script effective healthcare policies and strategies that are responsive to emerging trends. However, this real-world data is scattered across disparate sources such as electronic health records, medical claims, pharmacy transactions, and administrative registries. It needs to be powerfully integrated to gain the whole picture of healthcare.

This is where health data research experts like Health Research and Analysis (HRA), LLC brings value with its comprehensive analytical methodologies.

HRA places high emphasis on health economics and outcomes research to deliver actionable and contextual data for evidence-based decision-making in healthcare initiatives and social programs. They specialize in epidemiologic research, healthcare performance measurement, and policy/program evaluations for various public and private sector clients.

The firm uses a rigorous scientific and systematic approach to cleanse data from complex real-world databases to either assess the hypotheses of a program or shed light on the actual happenings. It decides on either a top-down or bottom-up approach based on client objectives.

HRA predominantly uses the top-down approach when conducting a study to measure a particular healthcare program, while the bottom-up approach is typically for identifying areas or opportunities for improvement and to give clients a clear view of the healthcare ecosystem for policy development. All approaches are adapted to the environment under study so that any derived insights are specific and applicable.

During research, HRA adapts industry standard methodologies to evaluate healthcare processes, outcomes, and costs while allowing for benchmarking. For example, HRA routinely looks at readmission rates and costs of episodes of care and then benchmarks the results against industry standards. The firm understands that merely representing a percent of the population is hardly enough and, as such, engages in rigorous epidemiologic methods that consider multiple covariates, including age, gender, race and ethnicity, and case mix, to cite a few.

In this regard, HRA takes a multivariate and systematic approach using different methodologies and metrics, including those of the Centers for Medicare and Medicaid Services (CMS), the National Committee for Quality Assurance (NCQA), and the Agency for Health Research and Quality (AHRQ).

“our value proposition is to provide data-driven insights that synergistically look at health outcomes along with cost. We bring in industry standards to compare one entity to the other based on best practices and established methodologies. Our research outcomes are not just a numerator and denominator,” says Samar DeBakey, president of HRA.

HRA also identifies anomalies, outliers, and areas that require further research or audits and articulates those findings’ challenges and limitations when delivering insights. The company discerns itself by embedding with the client and learning their programs to provide faster research outcomes without sticking to a cookie-cutter approach.

our value proposition is to provide data-driven insights that synergistically look at health outcomes along with cost. We bring in industry standards to compare one entity to the other based on best practices and established methodologies. Our research outcomes are not just a numerator and denominator

As a case study, Dr. DeBakey shared HRA’s key role in implementing the James Zadroga 9/11 Health and Compensation Act for the Responders and Survivors across New York City, Shanksville, and the Pentagon. The firm collaborated with the National Institute of Occupational Safety and Health (NIOSH) and the World Trade Center health program directors to translate the policy into practice. In this pursuit, HRA synergistically worked with clinical and IT departments to develop a healthcare (IT) system for adjudicating the medical claims to be covered by the program. HRA was instrumental, along with other partners, in getting the program up and running within six months. The firm’s role has matured, and HRA is now the program evaluator and HEOR partner in measuring program performance and identifying areas for improvement while engaging both top-down and bottom-up approaches to real-world program data. This instance exemplifies HRA’s nimble and adaptable capabilities.

HRA is also involved in research programs where the results of their work are often published in the peer-reviewed literature. An example is HRA’s collaboration with the Department of Defense in studying the health effects of deployment on Veterans. Scripting similar success stories, HRA plays an integral role in monitoring programs/policies as a whole, developing metrics and studies for specific hypotheses, and delivering necessary data as actionable insights for policymakers, program administrators, and researchers.

Top 10 HEOR Solutions Companies - 2022
Current Issue

Company : Health Research and Analysis - HRA

Management
Samar DeBakey, MD, MPH, president.

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/health-research-and-analysis-hra